Logo image of CPRT

COPART INC (CPRT) Stock Fundamental Analysis

NASDAQ:CPRT - US2172041061 - Common Stock

48.81 USD
+0.06 (+0.12%)
Last: 8/29/2025, 8:14:20 PM
48.9914 USD
+0.18 (+0.37%)
After Hours: 8/29/2025, 8:14:20 PM
Fundamental Rating

7

CPRT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. CPRT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CPRT is quite expensive at the moment. It does show a decent growth rate. These ratings would make CPRT suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CPRT was profitable.
CPRT had a positive operating cash flow in the past year.
Each year in the past 5 years CPRT has been profitable.
CPRT had a positive operating cash flow in each of the past 5 years.
CPRT Yearly Net Income VS EBIT VS OCF VS FCFCPRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

CPRT's Return On Assets of 15.29% is amongst the best of the industry. CPRT outperforms 94.05% of its industry peers.
CPRT has a better Return On Equity (16.84%) than 80.95% of its industry peers.
The Return On Invested Capital of CPRT (14.50%) is better than 90.48% of its industry peers.
CPRT had an Average Return On Invested Capital over the past 3 years of 19.14%. This is significantly above the industry average of 10.65%.
The 3 year average ROIC (19.14%) for CPRT is well above the current ROIC(14.50%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 15.29%
ROE 16.84%
ROIC 14.5%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
CPRT Yearly ROA, ROE, ROICCPRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 32.21%, CPRT belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
In the last couple of years the Profit Margin of CPRT has grown nicely.
With an excellent Operating Margin value of 35.80%, CPRT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRT has remained more or less at the same level.
Looking at the Gross Margin, with a value of 44.51%, CPRT is in the better half of the industry, outperforming 79.76% of the companies in the same industry.
In the last couple of years the Gross Margin of CPRT has remained more or less at the same level.
Industry RankSector Rank
OM 35.8%
PM (TTM) 32.21%
GM 44.51%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
CPRT Yearly Profit, Operating, Gross MarginsCPRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CPRT is creating value.
CPRT has more shares outstanding than it did 1 year ago.
CPRT has more shares outstanding than it did 5 years ago.
CPRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CPRT Yearly Shares OutstandingCPRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPRT Yearly Total Debt VS Total AssetsCPRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPRT has an Altman-Z score of 34.51. This indicates that CPRT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 34.51, CPRT belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
CPRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 34.51
ROIC/WACC1.64
WACC8.87%
CPRT Yearly LT Debt VS Equity VS FCFCPRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

CPRT has a Current Ratio of 8.16. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
CPRT has a Current ratio of 8.16. This is amongst the best in the industry. CPRT outperforms 96.43% of its industry peers.
A Quick Ratio of 8.09 indicates that CPRT has no problem at all paying its short term obligations.
CPRT has a better Quick ratio (8.09) than 96.43% of its industry peers.
Industry RankSector Rank
Current Ratio 8.16
Quick Ratio 8.09
CPRT Yearly Current Assets VS Current LiabilitesCPRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.57% over the past year.
The Earnings Per Share has been growing slightly by 4.32% on average over the past years.
CPRT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
The Revenue has been growing by 15.72% on average over the past years. This is quite good.
EPS 1Y (TTM)8.57%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%7.69%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%7.49%

3.2 Future

CPRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.98% yearly.
CPRT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.53% yearly.
EPS Next Y14.15%
EPS Next 2Y12.6%
EPS Next 3Y12.7%
EPS Next 5Y11.98%
Revenue Next Year9.9%
Revenue Next 2Y9.14%
Revenue Next 3Y9.38%
Revenue Next 5Y11.53%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CPRT Yearly Revenue VS EstimatesCPRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CPRT Yearly EPS VS EstimatesCPRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 32.11, which means the current valuation is very expensive for CPRT.
CPRT's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.13. CPRT is around the same levels.
Based on the Price/Forward Earnings ratio of 27.69, the valuation of CPRT can be described as expensive.
CPRT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CPRT to the average of the S&P500 Index (22.76), we can say CPRT is valued slightly more expensively.
Industry RankSector Rank
PE 32.11
Fwd PE 27.69
CPRT Price Earnings VS Forward Price EarningsCPRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPRT is on the same level as its industry peers.
CPRT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 39.95
EV/EBITDA 21.95
CPRT Per share dataCPRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CPRT may justify a higher PE ratio.
CPRT's earnings are expected to grow with 12.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.27
PEG (5Y)7.43
EPS Next 2Y12.6%
EPS Next 3Y12.7%

0

5. Dividend

5.1 Amount

No dividends for CPRT!.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (8/29/2025, 8:14:20 PM)

After market: 48.9914 +0.18 (+0.37%)

48.81

+0.06 (+0.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-22 2025-05-22/amc
Earnings (Next)09-04 2025-09-04/amc
Inst Owners86.64%
Inst Owner Change-0.85%
Ins Owners8.65%
Ins Owner Change0.68%
Market Cap47.20B
Analysts77.78
Price Target60.4 (23.75%)
Short Float %3.22%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.26%
Min EPS beat(2)-1.18%
Max EPS beat(2)5.7%
EPS beat(4)1
Avg EPS beat(4)-1.84%
Min EPS beat(4)-10.92%
Max EPS beat(4)5.7%
EPS beat(8)3
Avg EPS beat(8)-1.19%
EPS beat(12)6
Avg EPS beat(12)-0.45%
EPS beat(16)10
Avg EPS beat(16)0.61%
Revenue beat(2)1
Avg Revenue beat(2)-1.24%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)0.81%
Revenue beat(4)2
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.44%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)10
Avg Revenue beat(16)1.04%
PT rev (1m)-2.13%
PT rev (3m)-5.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE 32.11
Fwd PE 27.69
P/S 10.28
P/FCF 39.95
P/OCF 26.21
P/B 5.37
P/tB 5.76
EV/EBITDA 21.95
EPS(TTM)1.52
EY3.11%
EPS(NY)1.76
Fwd EY3.61%
FCF(TTM)1.22
FCFY2.5%
OCF(TTM)1.86
OCFY3.81%
SpS4.75
BVpS9.08
TBVpS8.48
PEG (NY)2.27
PEG (5Y)7.43
Profitability
Industry RankSector Rank
ROA 15.29%
ROE 16.84%
ROCE 18.23%
ROIC 14.5%
ROICexc 28.23%
ROICexgc 32.32%
OM 35.8%
PM (TTM) 32.21%
GM 44.51%
FCFM 25.73%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
ROICexc(3y)30.14%
ROICexc(5y)28.88%
ROICexgc(3y)50.08%
ROICexgc(5y)42.59%
ROCE(3y)24.07%
ROCE(5y)25.2%
ROICexcg growth 3Y-0.59%
ROICexcg growth 5Y-0.42%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y0.83%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 288.39%
Cap/Sales 13.49%
Interest Coverage 521.3
Cash Conversion 96.88%
Profit Quality 79.89%
Current Ratio 8.16
Quick Ratio 8.09
Altman-Z 34.51
F-Score5
WACC8.87%
ROIC/WACC1.64
Cap/Depr(3y)278.53%
Cap/Depr(5y)355.91%
Cap/Sales(3y)11.68%
Cap/Sales(5y)15.82%
Profit Quality(3y)72%
Profit Quality(5y)63.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.57%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%7.69%
EPS Next Y14.15%
EPS Next 2Y12.6%
EPS Next 3Y12.7%
EPS Next 5Y11.98%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%7.49%
Revenue Next Year9.9%
Revenue Next 2Y9.14%
Revenue Next 3Y9.38%
Revenue Next 5Y11.53%
EBIT growth 1Y2.53%
EBIT growth 3Y11.42%
EBIT growth 5Y17.02%
EBIT Next Year17.3%
EBIT Next 3Y14.05%
EBIT Next 5Y13.89%
FCF growth 1Y35.89%
FCF growth 3Y22.13%
FCF growth 5Y28.66%
OCF growth 1Y36.56%
OCF growth 3Y14.12%
OCF growth 5Y17.89%